Cargando…

Understanding safety differently: developing a model of resilience in the use of intravenous insulin infusions in hospital in-patients—a feasibility study protocol

BACKGROUND: Intravenous insulin infusions are considered the treatment of choice for critically ill patients and non-critically ill patients with persistent raised blood glucose who are unable to eat, to achieve optimal blood glucose levels. The benefits of using intravenous insulin infusions as wel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iflaifel, Mais Hasan, Lim, Rosemary, Ryan, Kath, Crowley, Clare, Iedema, Rick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624105/ https://www.ncbi.nlm.nih.gov/pubmed/31296514 http://dx.doi.org/10.1136/bmjopen-2019-029997

Ejemplares similares

Detailed analysis of ‘work as imagined’ in the use of intravenous insulin infusions in a hospital: a hierarchical task analysis
por: Iflaifel, Mais Hasan, et al.
Publicado: (2021)

Using video reflexive ethnography to explore the use of variable rate intravenous insulin infusions
por: Iflaifel, Mais, et al.
Publicado: (2022)

Resilient Health Care: a systematic review of conceptualisations, study methods and factors that develop resilience
por: Iflaifel, Mais, et al.
Publicado: (2020)

Subcutaneous fast-acting insulin analogues, alone or in combination with long-acting insulin, versus intravenous regular insulin infusion in patients with diabetic ketoacidosis: protocol for an updated systematic review and meta-analysis of randomised trials
por: Lim, Beng Leong, et al.
Publicado: (2023)

Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?
por: Rosinha, Patrícia, et al.
Publicado: (2022)

Treating Hypertriglyceridemia-Induced Pancreatitis With Intravenous Insulin and Plasmapheresis
por: Ng, Lay She, et al.
Publicado: (2022)

Diabetic Ketoacidosis, Very Severe Hypertriglyceridemia, and Pseudohyponatremia Successfully Managed With Insulin Infusion
por: Ibrahim, Ramzi, et al.
Publicado: (2020)

HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment
por: Scott, Emma S, et al.
Publicado: (2019)

Effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections on glycaemic control among older adults with type 2 diabetes: protocol for systematic review and meta-analysis
por: Yang, Bei, et al.
Publicado: (2023)

‘Striving for freedom or remaining with what is well-known’: a focus-group study of self-management among people with type 1 diabetes who have suboptimal glycaemic control despite continuous subcutaneous insulin infusion
por: Persson, Margareta, et al.
Publicado: (2022)

EXercise to Prevent frailty and Loss Of independence in insulin treated older people with DiabetEs (EXPLODE): protocol for a feasibility randomised controlled trial (RCT)
por: Stocker, Rachel, et al.
Publicado: (2021)

Dietary Approaches to the Management Of type 2 Diabetes (DIAMOND): protocol for a randomised feasibility trial
por: Morris, Elizabeth, et al.
Publicado: (2019)

Efficacy and Safety of Intravenous Insulin in Treatment of Patient With Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis
por: Alshurtan, Kareema S, et al.
Publicado: (2022)

PSUN220 Audit on Variable Rate Intravenous Insulin Infusion (VRIII) in inpatients in Scarborough General Hospital
por: Abraham, Santhosh, et al.
Publicado: (2022)

Web-based intervention to reduce psychological barriers to insulin therapy among adults with non-insulin-treated type 2 diabetes: study protocol for a two-armed randomised controlled trial of ‘Is insulin right for me?’
por: Holmes-Truscott, Elizabeth, et al.
Publicado: (2022)

Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational study
por: Oram, Richard A, et al.
Publicado: (2013)

Feasibility, acceptability and outcomes at a 12-month follow-up of a novel community-based intervention to prevent type 2 diabetes in adults at high risk: mixed methods pilot study
por: Penn, Linda, et al.
Publicado: (2013)

PSUN173 Factors determining insulin dose while transitioning from intravenous insulin infusion to subcutaneous insulin in patients with type 2 diabetes following cardiac bypass surgery.
por: Bansal, Beena, et al.
Publicado: (2022)

The role of polycarbonate monomer bisphenol-A in insulin resistance
por: Pjanic, Milos
Publicado: (2017)

‘Is Insulin Right for Me?’ Development of a theory-informed, web-based resource for reducing psychological barriers to insulin therapy in type 2 diabetes
por: Holloway, Edith E, et al.
Publicado: (2021)

Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus—the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial
por: Lundby-Christensen, Louise, et al.
Publicado: (2016)

Cultural adaptation of a patient decision-aid for insulin therapy
por: Tan, Ngiap Chuan, et al.
Publicado: (2020)

Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study
por: Wang, Li, et al.
Publicado: (2013)

The association between cytokines and insulin sensitivity in Iraqi immigrants and native Swedes
por: Memon, Ashfaque A, et al.
Publicado: (2013)

Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis
por: Freemantle, Nick, et al.
Publicado: (2016)

Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D Feasibility): a randomised feasibility trial protocol
por: Farmer, Andrew, et al.
Publicado: (2019)

A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands
por: de Groot, Saskia, et al.
Publicado: (2018)

Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial
por: Lundby-Christensen, Louise, et al.
Publicado: (2016)

Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
por: Ziegler, Anette-Gabriele, et al.
Publicado: (2019)

CopenFast trial: Faster-acting insulin Fiasp versus insulin NovoRapid in the treatment of women with type 1 or type 2 diabetes during pregnancy and lactation - a randomised controlled trial
por: Nørgaard, Sidse Kjærhus, et al.
Publicado: (2021)

Does intensive glycaemic control promote healing in diabetic foot ulcers? – a feasibility study
por: Dissanayake, Ajith, et al.
Publicado: (2020)

Understanding the cost of care of type 2 diabetes mellitus - a value measurement perspective
por: Doyle, Gerardine Anne, et al.
Publicado: (2022)

Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix® 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study
por: Shah, S, et al.
Publicado: (2009)

Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol
por: Boughton, Charlotte, et al.
Publicado: (2020)

The association between insulin therapy and depression in patients with type 2 diabetes mellitus: a meta-analysis
por: Bai, Xiaosu, et al.
Publicado: (2018)

Assessment of eight insulin resistance surrogate indexes for predicting metabolic syndrome and hypertension in Thai law enforcement officers
por: Rattanatham, Rujikorn, et al.
Publicado: (2023)

Identifying clinical criteria to predict Type 1 diabetes, as defined by absolute insulin deficiency: a systematic review protocol
por: Shields, Beverley M, et al.
Publicado: (2012)

Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic review
por: Price, Hilary I, et al.
Publicado: (2015)

Resveratrol reduces the inflammatory response in adipose tissue and improves adipose insulin signaling in high-fat diet-fed mice
por: Ding, Shibin, et al.
Publicado: (2018)

What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries
por: Boels, Anne Meike, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ufg1pnjntpbon5lmv00nsoqgjm